[www.umc.com Description 99.1 Announcement on 2017/07/27: Represent subsidiary TLC Capital Co., Ltd. to announce related materials on disposal of common shares of SuperAlloy Industrial Co., Ltd. 99.2 Announcement on 2017/07/28: Represent subsidiary United Semiconductor (Xiamen) Co., Ltd. to announce ]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
[www.umc.com Description 99.1 Announcement on 2017/07/27: Represent subsidiary TLC Capital Co., Ltd. to announce related materials on disposal of common shares of SuperAlloy Industrial Co., Ltd. 99.2 Announcement on 2017/07/28: Represent subsidiary United Semiconductor (Xiamen) Co., Ltd. to announce ]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
[ReneSola Receives Notice Regarding NYSE Listing Criteria and Enters Into Term Sheet with Respect to Potential Disposition of Certain Businesses and Liabilities www.renesola.com SHANGHAI, August 26, 2017 /PRNewswire/ ReneSola Ltd (“ReneSola” or the “Company”) ( The Company is considered below criteri]
[ReneSola Receives Notice Regarding NYSE Listing Criteria and Enters Into Term Sheet with Respect to Potential Disposition of Certain Businesses and Liabilities www.renesola.com SHANGHAI, August 26, 2017 /PRNewswire/ ReneSola Ltd (“ReneSola” or the “Company”) ( The Company is considered below criteri]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, August 28, 2017 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on August 22,]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, August 28, 2017 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on August 22,]
